I totally agree thrifty, Giamcoma and BMK (sp). It would be prudent for both regulatory agencies to wait for at least the death count on both arms of the S/C trial to show that the M2M was not just a whim but both trials would definitely put the onus on both agencies to approve at that point. Many here have said that we should know at least the deaths on both arms by around September 28th or so.

I sure hate to wait for all that to come about but do we have any choices? Leronlimab is new, very new to these agencies as Leronlimab doesn't work at the virus or Influenza's or even Cancer like other drugs attack them. We are a totally new suit of armor that does what other pharmas haven't been able to do yet so this process needs to be examined like never b4 so just do what an old MB friend of mine and it's his handle on another bio-tech which is " Waitforit " - GLT all three of you and just wait for it to come out in the open

HCIT